Paced by Life Sciences and Diagnostics Business, Danaher Q2 Revenues Increase 5 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Danaher today reported that its revenues for the second quarter increased 5 percent year over year, narrowly missing the consensus analyst estimate on the top line but topping expectations on the bottom line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.